Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1038/s41598-017-03675-z
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2017
- Creator
-
Cabrera, Daniel
Wree, Alexander
Povero, Davide
Solís, Nancy
Hernandez, Alejandra
Pizarro, Margarita
Moshage, Han
Torres, Javiera
Feldstein, Ariel E.
Cabello-Verrugio, Claudio
Brandan, Enrique
Barrera, Francisco
Arab, Juan Pablo
Arrese, Marco
- DOI
-
10.18154/RWTH-CONV-221678
- URN
-
urn:nbn:de:101:1-2020081313163149141532
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cabrera, Daniel
- Wree, Alexander
- Povero, Davide
- Solís, Nancy
- Hernandez, Alejandra
- Pizarro, Margarita
- Moshage, Han
- Torres, Javiera
- Feldstein, Ariel E.
- Cabello-Verrugio, Claudio
- Brandan, Enrique
- Barrera, Francisco
- Arab, Juan Pablo
- Arrese, Marco
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2017
Other Objects (12)
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
Analysis of non-alcoholic beverages